quinoxalines has been researched along with Brain Damage, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, S; Pang, L; Xing, J | 1 |
| Andiné, P; Diemer, NH; Gilland, E; Hagberg, H | 1 |
| Balchen, T; Bruhn, T; Christensen, T; Diemer, NH; Johansen, FF; Nielsen, M; Vanicky, I | 1 |
| Bart, RD; Brinkhous, A; Pearlstein, R; Takaoka, S; Warner, DS | 1 |
| Lo, EH; Mandeville, JB; Pierce, AR; Rosen, BR | 1 |
| Diemer, NH; Honoré, T; Johansen, FF; Jørgensen, MB; Sheardown, M | 1 |
6 other study(ies) available for quinoxalines and Brain Damage, Chronic
| Article | Year |
|---|---|
Amiloride Alleviates Neurological Deficits Following Transient Global Ischemia and Engagement of Central IL-6 and TNF-α Signal.
Topics: Acid Sensing Ion Channels; Amiloride; Animals; Asphyxia; Brain Damage, Chronic; Brain Edema; Caspase 3; Caspase 9; Drug Evaluation, Preclinical; Hippocampus; Hydrazines; Interleukin-6; Ischemic Attack, Transient; Male; Quinoxalines; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Up-Regulation | 2019 |
Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists.
Topics: Animals; Animals, Newborn; Brain Damage, Chronic; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Hypoxia, Brain; Injections, Intraperitoneal; Male; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Severity of Illness Index; Treatment Outcome | 1994 |
Extended studies on the effect of glutamate antagonists on ischemic CA-1 damage.
Topics: Animals; Brain Damage, Chronic; Brain Ischemia; Brain Mapping; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Male; Neurons; Premedication; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 1996 |
Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
Topics: Animals; Binding Sites; Brain Damage, Chronic; Brain Ischemia; Cerebral Infarction; Excitatory Amino Acid Antagonists; Fever; Glycine; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Temperature | 1997 |
Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
Topics: Animals; Body Water; Brain Damage, Chronic; Brain Edema; Brain Ischemia; Cerebral Infarction; Diffusion; Excitatory Amino Acid Antagonists; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1997 |
Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX.
Topics: Animals; Brain Damage, Chronic; Brain Ischemia; Cell Count; Hippocampus; Male; Nerve Degeneration; Neurons; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1992 |